Personal information

No personal information available

Activities

Collapse all

Employment (1)

EPO GmbH: Berlin, Berlin, DE

2006-03-01 to present | Research Project Manager/ QMB/ Safety officer
Employment
Source: Self-asserted source
Marlen Keil

Education and qualifications (3)

Deutsche Gesellschaft für Qualität DGQ Service GmbH: Frankfurt, Hessen, DE

2017-09-18 to 2017-09-28 | Quality management representative and internal auditor (Quality Management)
Qualification
Source: Self-asserted source
Marlen Keil

Charité Universitätsmedizin Berlin: Berlin, Berlin, DE

2007-07-01 to 2015-12-01 | Dr. rer. med (Medical Science)
Education
Source: Self-asserted source
Marlen Keil

University of applied Sciences Jena: Jena, Thuringia, DE

2001-09-01 to 2006-02-28 | Diplom Ingeneer (FH) (Biotechnology)
Education
Source: Self-asserted source
Marlen Keil

Professional activities (1)

European Association For Cancer Research: Nottingham, Nottingham, GB

2017-04-20 to present | EACR Ambassador
Membership
Source: Self-asserted source
Marlen Keil

Works (7)

Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data

Cancers
2021-11-30 | Journal article
DOI: 10.3390/cancers13236018
Contributors: Marlen Keil; Theresia Conrad; Michael Becker; Ulrich Keilholz; Marie-Laure Yaspo; Hans Lehrach; Moritz Schütte; Johannes Haybaeck; Jens Hoffmann
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

High Yap and Mll1 promote a persistent regenerative cell state induced by Notch signaling and loss of p53

Proceedings of the National Academy of Sciences
2021-06-01 | Journal article
DOI: 10.1073/pnas.2019699118
Part of ISSN: 0027-8424
Part of ISSN: 1091-6490
Source: Self-asserted source
Marlen Keil
grade
Preferred source (of 2)‎

Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.

Oncotarget
2017-09-05 | Journal article
DOI: 10.18632/oncotarget.20642
PMID: 29254159
PMC: PMC5731869
Source: Self-asserted source
Marlen Keil

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Nature communications
2017-02-10 | Journal article
DOI: 10.1038/ncomms14262
PMID: 28186126
PMC: PMC5309787
Source: Self-asserted source
Marlen Keil

Cell differentiation mediated by co-culture of human umbilical cord blood stem cells with murine hepatic cells.

In vitro cellular & developmental biology. Animal
2014-10-01 | Journal article
DOI: 10.1007/s11626-014-9817-3
PMID: 25270685
Source: Self-asserted source
Marlen Keil

Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo.

In vitro cellular & developmental biology. Animal
2012-02-04 | Journal article
DOI: 10.1007/s11626-012-9487-y
PMID: 22311374
Source: Self-asserted source
Marlen Keil

Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.

Tissue & cell
2011-12-23 | Journal article
DOI: 10.1016/j.tice.2011.11.004
PMID: 22197619
Source: Self-asserted source
Marlen Keil
How many people are using ORCID?